January 31, 2023

Health Systems Will Need a Tech Transformation to Prepare for CMS Glycemia Measures

January 2, 2023 Jordan Messler, MD, SFHM, FACP Health Systems Will Need a Tech Transformation to Prepare for CMS Glycemia Measures In a previous article published on AJMC.com, I explored why CMS finally decided to put its muscle behind glycemic management. The column was generated in response to revisions CMS made to its Hospital Inpatient Quality Reporting Program, which is …

January 9, 2023

26 patient safety experts to know | 2022

December 28, 2022 Brendan Talian 26 patient safety experts to know | 2022 Becker’s Healthcare is thrilled to reveal the 2022 edition of its list, “26 patients safety experts to know.” The professionals included on this list are prominent advocates for patient safety. They are clinicians, researchers and experts who focus on improving healthcare for large populations. Many honorees have …

January 6, 2023

Improving Glycemic Management for Better Outcomes, Cost Savings

December 7, 2022 Maria Asimopoulos Improving Glycemic Management for Better Outcomes, Cost Savings Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes. Read the full transcript: Welcome back to PopHealth Perspectives, a conversation with the Population Health Learning Network, where we combine …

November 9, 2022

MANAGE YOUR HOSPITALIZED DIABETIC PATIENTS TO IMPROVE OUTCOMES AND LOWER COST OF CARE

October 31, 2022 By Christopher Cheney MANAGE YOUR HOSPITALIZED DIABETIC PATIENTS TO IMPROVE OUTCOMES AND LOWER COST OF CARE Compared to other hospitalized patients, patients with diabetes have longer lengths of stay and higher readmission rates. KEY TAKEAWAYS Riverside Healthcare found that better management of hypoglycemic patients at their facility led to an estimated savings of $544,756 annually. Patients with diabetes …

July 13, 2022

CMS Gives Glycemic Management Committees the Leverage they Need to Prioritize Change

JUNE 24 2022 By Jordan Messler, MD, SFHM, FACP CMS Gives Glycemic Management Committees the Leverage they Need to Prioritize Change Glycemic management is an often-overlooked or under-prioritized area of inpatient care. Despite a mountain of evidence that shows how high and low blood glucose can negatively impact the quality and costs of care, there’s a conventional belief that monitoring …

June 1, 2022

How Glytec is advancing insulin management in the hospital

May 31, 2022 By Sean Whooley How Glytec is advancing insulin management in the hospital After years of running a hospitalist group and mentoring hospitals on quality improvement, blood clot prevention and more, Dr. Jordan Messler found himself falling into a lot of work on diabetes. Messler cut his teeth on quality improvement around diabetes, observing that inpatient glycemia impacts …

February 9, 2022

Strategic Partnership Will Bring Digital Health Innovation to the Hospital Bedside

February 2022 Strategic Partnership Will Bring Digital Health Innovation to the Hospital Bedside Glytec and Roche Diagnostics USA last month announced a digital health collaboration that combines Roche’s expertise in medical devices and IT solutions with Glytec’s FDA-cleared insulin dosing decision support software, Glucommander™, to address the pervasive challenges with inpatient blood sugar management at the hospital bedside. Glucommander will …

September 24, 2021

Why the Next Wave of Insulin Innovation Needs to Focus on Inpatient Management

AUGUST 22 2021 By Dr. Jordan Messler Why the Next Wave of Insulin Innovation Needs to Focus on Inpatient Management In 1921, Sir Frederick G. Banting, Charles H. Best and JJR Macleod discovered insulin at the University of Toronto. This innovation changed the course of history for individuals with type 1 diabetes, caregivers and others who require insulin. The 100 …

July 16, 2021

John Downey, Chief Commercial Officer at Glytec, on VatorNews podcast

JULY 14 2021 Steven Loeb John Downey, Chief Commercial Officer at Glytec, on VatorNews podcast Glytec’s electronic glycemic management system uses data to determine patient insulin levels Steven Loeb and Bambi Francisco interview John Downey, Chief Commercial Officer at Glytec, a provider of electronic glycemic management systems (eGMS), using real-time data to ensure that hospitals give patients the right level of insulin. …

July 15, 2021

Glytec appoints chief medical officer

JULY 13 2021 Sean Whooley Glytec appoints chief medical officer Cloud-based insulin management software developer Glytec announced today that it appointed Dr. Jordan Messler as chief medical officer. Messler’s responsibilities as the company’s CMO include spearheading continuous improvement initiatives for Glytec’s clinical strategy and product development. Additionally, Messler will be supporting the delivery, customer, quality and regulatory teams to ensure ethical …

May 17, 2021

Glytec Raises $21 Million

APRIL 26 2021 Glytec Raises $21 Million Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department. The combined $9 million …

Glytec Lands $21M Venture & Debt Funding

APRIL 26 2021 Glytec Lands $21M Venture & Debt Funding WALTHAM, MA, Glytec, a provider of insulin management software, announced $21 million in financing. >> Click here for more funding data on Glytec >> To export Glytec funding data to PDF and Excel, click here Glytec, a provider of insulin management software, announced $21 million in financing from Silicon Valley …

May 15, 2021

Most Riveting Takeaways from the Medtech Design Summit 2021

MAY 13 2021 Amanda Pedersen Most Riveting Takeaways from the Medtech Design Summit 2021 Finalists in the 2021 Medical Design Excellence Awards program shared best practices and lessons learned from the design process. These were among the most compelling takeaways from the discussions. The Medtech Design Summit is available to watch on demand here. View slideshow: https://www.mddionline.com/design-engineering/most-riveting-takeaways-medtech-design-summit-2021/gallery?slide=1 – This article originally …

May 14, 2021

Medical Design Excellence Awards (MDEA) Unveils 2021 Winners

MAY 13 2021 Medical Design Excellence Awards (MDEA) Unveils 2021 Winners SANTA MONICA, Calif.–(BUSINESS WIRE)–Medical Design Excellence Awards (MDEA), a prestigious award program recognizing cutting-edge achievements in medical product design, today announced the 2021 winners during the all-new Medtech Design Summit, during which Novo; Protolabs; HS Design, a SteriPack company; and Trelleborg sponsored sessions and Bressler Group, Inertia Engineering, and …

May 10, 2021

Glytec Raises $21M to Fix Hospital Insulin Management

APRIL 26 2021 Fred Pennic Glytec Raises $21M to Fix Hospital Insulin Management What You Should Know: – Glytec announced $21M in funding today from Silicon Valley Bank, Savitr Capital and others to help address the challenge that 90% of hospitals in the U.S. face with insulin management. – Glytec’s insulin management solution, eGMS helps providers track blood glucose data, detect and alert patients in glycemic disarray, provide personalized insulin dosing regimens, and …

Glytec Raises $21 Million To Set the Standard for Hospital Insulin Dosing and Glycemic Management

APRIL 26 2021 Glytec Raises $21 Million To Set the Standard for Hospital Insulin Dosing and Glycemic Management WALTHAM, MASS. (April 26, 2021) – Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. Editor’s Note: This article originally posted …

Insulin management company Glytec scores $21M to fuel growth

APRIL 27 2021 Mallory Hackett Insulin management company Glytec scores $21M to fuel growth The company collected $9 million in debt financing from SVB and $12 million in equity investments led by Savitr positions, according to its announcement. Glytec, an insulin management software company, has received $21 million in funding from Silicon Valley Bank, Savitr Capital and other private investors. …

Glytec raises $21M for insulin dosing management tech

APRIL 26 2021 Sean Whooley Glytec raises $21M for insulin dosing management tech Glytec announced today that it raised $21 million in financing to fund its glycemic management technology. Waltham, Mass.-based Glytec received $9 million in debt financing from Silicon Valley Bank, combined with $12 million in equity funding, led by Savitr with contribution from other private investors, according to a …

Glytec Raises $21M in Funding

APRIL 27 2021 Glytec Raises $21M in Funding Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing. The financing included:$9m debt financing from SVB, and$12m equity investment led by Savitr Capital and other private investors. Led by Ed Furlong, President and Chief Executive Officer, Glytec is an insulin management software company …